B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: A prognostic study

BMC Cardiovascular Disorders

Volumn 8, Issue , 2008, Pages

  Brügger Andersen, Trygve ^a,b   Pönitz, Volker ^a,b   Staines, Harry ^c   Pritchard, David ^d   Grundt, Heidi ^a,b   Nilsen, Dennis W T ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

^c Sigma Statistical Services   (United Kingdom)

^d Axis Shield Diagnostics Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; TROPONIN T; BIOLOGICAL MARKER;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE MARKER; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION; SURVIVAL TIME; THORAX PAIN; ACUTE CORONARY SYNDROME; BLOOD; FOLLOW UP; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; RISK FACTOR; SURVIVAL; TIME;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHEST PAIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TROPONIN T;

EID: 61349086166     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-8-34     Document Type: Article

References (34)

1. Maeda K Tsutamoto T Wada A Hisanaga T Kinoshita M Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction Am Heart J 1998, 135:825-32 10.1016/S0002-8703(98)70041-9 9588412
2. Nakagawa O Ogawa Y Itoh H Suga S Komatsu Y Kishimoto I Nishino K Yoshimasa T Nakao K Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload J Clin Invest 1995, 96:1280-7 185749 7657802 10.1172/JCI118162
3. Richards AM Nicholls MG Espiner EA Lainchbury JG Troughton RW Elliott J Frampton C Turner J Crozier IG Yandle TG B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction Circulation 2003, 107:2786-92 10.1161/01.CIR.0000070953.76250.B9 12771003
4. de Lemos JA Morrow DA Bentley JH Omland T Sabatine MS McCabe CH Hall C Cannon CP Braunwald E The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 2001, 345:1014-21 10.1056/NEJMoa011053 11586953
5. Morrow DA de Lemos JA Sabatine MS Murphy SA Demopoulos LA Dibattiste PM McCabe CH Gibson CM Cannon CP Braunwald E Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/ non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18 J Am Coll Cardiol 2003, 41:1264-72 10.1016/ S0735-1097(03)00168-2 12706919
6. Omland T Persson A Ng L O'Brien R Karlsson T Herlitz J Hartford M Caidahl K N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes Circulation 2002 106:2913-8 10.1161/01.CIR.0000041661.63285.AE 12460871
7. Ross R Atherosclerosis-an inflammatory disease N Engl J Med 1999, 340:115-26 10.1056/NEJM199901143400207 9887164
8. Liuzzo G Biasucci LM Gallimore JR Grillo RL Rebuzzi AG Pepys MB Maseri A The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina N Engl J Med 1994, 331:417-24 10.1056/ NEJM199408183310701 7880233
9. Berk BC Weintraub WS Alexander RW Elevation of C-reactive protein in "active" coronary artery disease Am J Cardiol 1990, 65:168-72 10.1016/0002-9149(90)90079-G 2296885
10. de Lemos JA The latest and greatest new biomarkers: Which ones should we measure for risk prediction in our practice? Arch Intern Med 2006, 166:2428-30 10.1001/archinte.166.22.2428 17159006
11. Rothenbacher D Koenig W Brenner H Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease Arch Intern Med 2006, 166:2455-60 10.1001/archinte.166.22.2455 17159010
12. Kim H Yang DH Park Y Han J Lee H Kang H Park HS Cho Y Chae SC Jun JE Park WH Incremental prognostic value of C-reactive protein and N-terminal proB-type natriuretic peptide in acute coronary syndrome Circ J 2006, 70:1379-84 10.1253/circj.70.1379 17062957
13. Sabatine MS Morrow DA de Lemos JA Gibson CM Murphy SA Rifai N McCabe C Antman EM Cannon CP Braunwald E Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide Circulation 2002, 105:1760-3 10.1161/ 01.CIR.0000015464.18023.0A 11956114
14. Ndrepepa G Kastrati A Braun S Mehilli J Niemoller K von BN von BO Vogt W Schomig A N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease Am J Med 2006, 119:355-8 10.1016/ j.amjmed.2005.10.060 16564781
15. Muller-Bardorff M Hallermayer K Schroder A Ebert C Borgya A Gerhardt W Remppis A Zehelein J Katus HA Improved troponin T ELISA specific for cardiac troponin T isoform: Assay development and analytical and clinical validation Clin Chem 1997, 43:458-66 9068589
16. Antman EM Cohen M Bernink PJ McCabe CH Horacek T Papuchis G Mautner B Corbalan R Radley D Braunwald E The TIMI risk score for unstable angina/ non-ST elevation MI: A method for prognostication and therapeutic decision making JAMA 2000, 284:835-42 10.1001/jama.284.7.835 10938172
17. Boersma E Pieper KS Steyerberg EW Wilcox RG Chang WC Lee KL Akkerhuis KM Harrington RA Deckers JW Armstrong PW Lincoff AM Califf RM Topol EJ Simoons ML Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators Circulation 2000, 101:2557-67 10840005
18. Lindahl B Toss H Siegbahn A Venge P Wallentin L Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease N Engl J Med 2000, 343:1139-47 10.1056/ NEJM200010193431602 11036119
19. Jernberg T Stridsberg M Venge P Lindahl B N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation J Am Coll Cardiol 2002, 40:437-45 10.1016/S0735-1097(02)01986-1 12142108
20. Omland T de Lemos JA Morrow DA Antman EM Cannon CP Hall C Braunwald E Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes Am J Cardiol 2002, 89:463-5 10.1016/S0002-9149(01)02271-8 11835931
21. Ballantyne CM Nambi V Markers of inflammation and their clinical significance Atheroscler Suppl 2005, 6:21-9 10.1016/ j.atherosclerosissup.2005.02.005 15823493
22. Kavsak PA MacRae AR Newman AM Lustig V Palomaki GE Ko DT Tu JV Jaffe AS Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure Clin Biochem 2007, 40:326-9 10.1016/j.clinbiochem.2006.10.025 17292342
23. Toss H Lindahl B Siegbahn A Wallentin L Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease Circulation 1997, 96:4204-10 9416883
24. Ridker PM Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 2003, 107:363-9 10.1161/ 01.CIR.0000053730.47739.3C 12551853
25. Burke AP Tracy RP Kolodgie F Malcom GT Zieske A Kutys R Pestaner J Smialek J Virmani R Elevated C-reactive protein values and atherosclerosis in sudden coronary death: Association with different pathologies Circulation 2002, 105:2019-23 10.1161/ 01.CIR.0000015507.29953.38 11980679
26. Casco VH Veinot JP Kuroski de Bold ML Masters RG Stevenson MM de Bold AJ Natriuretic peptide system gene expression in human coronary arteries J Histochem Cytochem 2002, 50:799-809 12019296
27. Maisel AS Krishnaswamy P Nowak RM McCord J Hollander JE Duc P Omland T Storrow AB Abraham WT Wu AH Clopton P Steg PG Westheim A Knudsen CW Perez A Kazanegra R Herrmann HC McCullough PA Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 2002, 347:161-7 10.1056/NEJMoa020233 12124404
28. Gerber IL Stewart RA Legget ME West TM French RL Sutton TM Yandle TG French JK Richards AM White HD Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis Circulation 2003, 107:1884-90 10.1161/01.CIR.0000060533.79248.0C 12668523
29. Beer S Golay S Bardy D Feihl F Gaillard RC Bachmann C Waeber B Ruiz J Increased plasma levels of N-terminal brain natriuretic peptide (NT-proBNP) in type 2 diabetic patients with vascular complications Diabetes Metab 2005, 31:567-73 10.1016/S1262-3636(07)70232-X 16357805
30. Olsen MH Christensen MK Hansen TW Gustafsson F Rasmussen S Wachtell K Borch-Johnsen K Ibsen H Jorgensen T Hildebrandt P High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors J Hypertens 2006, 24:655-61 16531793
31. de Winter RJ Stroobants A Koch KT Bax M Schotborgh CE Mulder KJ Sanders GT van Straalen JP Fischer J Tijssen JG Piek JJ Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention Am J Cardiol 2004, 94:1481-5 10.1016/j.amjcard.2004.08.023 15589000
32. Schnabel R Rupprecht HJ Lackner KJ Lubos E Bickel C Meyer J Munzel T Cambien F Tiret L Blankenberg S Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: Results from the AtheroGene study Eur Heart J 2005, 26:241-9 10.1093/eurheartj/ehi036 15618051
33. James SK Lindahl B Siegbahn A Stridsberg M Venge P Armstrong P Barnathan ES Califf R Topol EJ Simoons ML Wallentin L N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy Circulation 2003, 108:275-81 10.1161/01.CIR.0000079170.10579.DC 12847065
34. James SK Lindback J Tilly J Siegbahn A Venge P Armstrong P Califf R Simoons ML Wallentin L Lindahl B Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: A GUSTO-IV substudy J Am Coll Cardiol 2006, 48:1146-54 10.1016/j.jacc.2006.05.056 16978997